Summary: Featuring articles on baricitinib plus remdesivir for adults with Covid-19, albumin infusions in patients with cirrhosis, a trial of terlipressin for hepatorenal syndrome, nivolumab plus cabozantinib in renal-cell carcinoma, and on misrepresenting race; a review article on diffuse large B-cell lymphoma; a Clinical Problem-Solving describing a treacherous course; and Perspective articles on conquering atherosclerotic cardiovascular disease, on reform of payment for primary care, and on being without sanctuary. Supplement to the New England Journal of Medicine, Vol. 384, No. 9.
